Report overview
The global Uveitis Treatment Drug market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is to reach $ Million.
Corticosteroids Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Uveitis Treatment Drug include AbbVie, Novartis AG, Bausch Health Companies Inc., Galapagos NV, EyePoint Pharmaceuticals, Inc., Clearside Biomedical, Tarsier Pharma Ltd, Santen Pharmaceutical Co., Ltd. and Bausch & Lomb Incorporated, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Uveitis Treatment Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Uveitis Treatment Drug. This report contains market size and forecasts of Uveitis Treatment Drug in global, including the following market information:
Global Uveitis Treatment Drug Market Revenue, 2019-2024, 2025-2030, ($ millions)
Global top five companies in 2023 (%)
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Uveitis Treatment Drug companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Uveitis Treatment Drug Market, by Type, 2019-2024, 2025-2030 ($ millions)
Global Uveitis Treatment Drug Market Segment Percentages, by Type, 2023 (%)
Corticosteroids
Immunosuppressant
Monoclonal Antibodies
Antibiotics
Others
Global Uveitis Treatment Drug Market, by Application, 2019-2024, 2025-2030 ($ millions)
Global Uveitis Treatment Drug Market Segment Percentages, by Application, 2023 (%)
Anterior Uveitis
Posterior Uveitis
Intermediate Uveitis
Pan Uveitis
Global Uveitis Treatment Drug Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions)
Global Uveitis Treatment Drug Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Uveitis Treatment Drug revenues in global market, 2019-2024 (estimated), ($ millions)
Key companies Uveitis Treatment Drug revenues share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
AbbVie
Novartis AG
Bausch Health Companies Inc.
Galapagos NV
EyePoint Pharmaceuticals, Inc.
Clearside Biomedical
Tarsier Pharma Ltd
Santen Pharmaceutical Co., Ltd.
Bausch & Lomb Incorporated
Sanofi
Regeneron Pharmaceuticals, Inc.
Alimera Sciences
Outline of Major Chapters:
Chapter 1: Introduces the definition of Uveitis Treatment Drug, market overview.
Chapter 2: Global Uveitis Treatment Drug market size in revenue.
Chapter 3: Detailed analysis of Uveitis Treatment Drug company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Uveitis Treatment Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
